| Literature DB >> 31366641 |
Janet Jull1,2, Ian D Graham2, Elizabeth Kristjansson3, David Moher4, Jennifer Petkovic5, Manosila Yoganathan6, Peter Tugwell7, Vivian A Welch3.
Abstract
OBJECTIVE: We describe the use of an integrated knowledge translation (KT) approach in the development of the CONsolidated Standards Of Reporting Trials extension for equity ('CONSORT-Equity 2017'), and advisory board-research team members' ('the team') perceptions of the integrated KT process.Entities:
Keywords: collaborative research; consort; health equity; integrated knowledge translation; reporting guidelines; research co-creation
Mesh:
Year: 2019 PMID: 31366641 PMCID: PMC6678066 DOI: 10.1136/bmjopen-2018-026866
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Integrated knowledge translation (IKT) approach for CONsolidated Standards Of Reporting Trials extension for equity (CONSORT-Equity 2017).
Terms of reference
| Role of advisory board membership |
Members to participate in a collaborative process. Members will provide content-related support, and bring knowledge, skills and experience to the working group throughout the multiple stages of the research study process (ie, the integrated knowledge translation process including the end-of-grant dissemination). |
| Method and frequency of communication |
The facilitator (JJ) will provide background documents. Agendas to be provided in advance of meetings, with identification of key decisions to be made by the advisory board. There will be ongoing opportunities for communication, in a manner that facilitates the function of advisory board members in their roles. |
| Description of workload |
Meeting participation by members. Provision of feedback on key issues will be made in meetings or by email correspondence. There will be opportunities for interested advisory board members to meet authorship criteria (see below ‘Authorship’). |
| Timelines |
The advisory board involvement is anticipated to begin in June 2015 and end in December 2016. Meetings and/or updates will occur every 2–3 months (3–5 meetings/year, and with brief email correspondence). |
| How advice will be managed |
Advisory board input will be sought and considered along with that of the core research team. Disagreements on views will be respectfully and collaboratively managed by the advisory board facilitator (JJ). |
| Authorship |
Criteria outlined by the International Committee of Medical Journal Editors will be used to guide publication authorship. |
Stages in the development of CONSORT-Equity 2017 update terms
| Stage 1: establish guiding features | Example |
| 1. Find common ground. | A process to initiate and develop a collaborative work plan that for CONSORT-Equity 2017 was an iterative three-step process to prepare a research team. |
| 2. Form an advisory board. | Defined advisory board roles, accessed networks to recruit advisory board members; terms of reference to structure relationships within and between the advisory board-research team members (‘the team’) ( |
| 3. Commit to ethical guidance. | The team agreed on study conduct to adhere to ethical guidelines (in Canada, the Tri-Council Policy Statement V.2) |
| 4. Clarify theoretical perspective. | CONSORT-Equity 2017 is premised on understandings of key concepts, their definitions and usage by the team: understandings of health equity and agreements among team members about underpinning assumptions: the role of social determinants of health theory, a definition of ‘health equity’, defining a health equity-relevant randomised trial and when there is a health disadvantage, and that are reflected in publications. |
| Stage 2: research actions that supported the co-development of the reporting guideline. | The five reporting guideline development steps of stage 2 are bound by the guiding features of stage 1. |
| 1. Define. | Establish guideline need with the team: team members were engaged in a process to determine whether and how they might collaborate to develop an extension of CONSORT for equity. Following funding, further work among the team members resulted in a published protocol |
| 2. Assess. | Determine the state of the literature |
| 3. Develop/Adapt. | Propose and debate adaptation of the reporting guideline: identification of potential guideline knowledge users from high-income, middle-income and lower-income countries that include, for example, patients and methodologists, and who were invited to participate in an online Delphi study to identify items for the reporting guideline. |
| 4. Disseminate. | Develop and execute plan for uptake of the reporting guideline. |
| 5. Apply. | A process of road-testing the reporting guideline: work is under way to further disseminate and promote the application of the CONSORT-Equity 2017 guideline. |
CONSORT-Equity 2017, CONsolidated Standards Of Reporting Trials extension for equity.
Results of two Likert questions on a team survey about experience with integrated knowledge translation approach (n=24)
| Question | Response category | Illustrative quote from open-ended comments | ||||
| Overall, how would you rate the extent to which the research team engaged you in the project? (n=24) | 1 (not at all satisfied): n=0 (0%) | 2 (somewhat | 3 (satisfied): n=4 (16.6%) | 4 (very satisfied): n=3 (12.5%) | 5 (totally satisfied): n=15 (62.5%) | “I had a concrete role in the process and the team was very respectful and considerate of input so it was easy to feel invested.” |
| How satisfied are you with the level of your engagement with the research team? (n=24) | 1 (not at all satisfied): n=1 (4%) | 2 (somewhat | 3 (satisfied): n=2 (8%) | 4 (very satisfied): n=3 (12.5%) | 5 (totally satisfied): n=18 (75%) | “(I would) be happy (very) if all research teams engaged all participants in the same manner.” |
Results of six open-ended questions on a team survey about experience with an integrated knowledge translation approach (n=25)
| Question | Response |
| 1. What do you perceive as the benefits of an integrated KT approach to develop a reporting guideline extension of CONSORT for equity? | 1. Allows consideration and inclusion of a range of views (14/25, 56%): “Capturing a multitude of perspectives, to enhance relevance and acceptability of reporting guidelines across disciplines.” |
| 2. Do you think that the team faced any challenges in the study as the result of the integrated KT approach? | 1. The logistics of including a range of people in the team (8/25, 32%): “Takes more time to work with a large and diverse crowd.” |
| 3. Did you face any challenges in the study as the result of the integrated KT approach? | 1. No personal challenges faced in the study (19/25, 76%): “I did not face any challenges. My input and participation had equal standing in the process.” |
| 4. What do you consider to be the impact(s) of using an integrated KT approach with the study? | 1. Improves the final guideline product (11/25, 44%): “I feel that we produced a product that was relevant to all of our team members, and that they can support in their communities.” |
| 5. Would you have changed anything about how the integrated KT approach was used in the study? If yes, how? | 1. Would not change the use of the integrated KT approach (8/15, 53%): “No change suggested.” |
| 6. Do you have any additional comments? | 1. No comment (19/25, 76%). |
CONSORT, CONsolidated Standards Of Reporting Trials; KT, knowledge translation.